Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT05329649 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Sickle Cell Disease |
| Phase | Clinical Trial |
| Target Enrollment | 15 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Vertex Pharmaceuticals Incorporated |
| Last Updated on CT.gov | March 9, 2026 (Mar 9, 2026) |
As of April 17, 2026: Clinical trial NCT05329649 is currently active_not_recruiting participants. This clinical trial study for sickle cell disease is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Vertex Pharmaceuticals Incorporated. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05329649 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05329649 was last updated Mar 9, 2026 (March 9, 2026). HelloStudys verifies this status automatically.